Haemonetics Corp

Ownership Transactions Reported by 23 Insiders

Symbol
HAE on NYSE
Location
125 Summer Street, Boston, MA

Insiders trading volume in the past year

Haemonetics Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Simon President & CEO, Director $26.1M May 30, 2025
Josep Llorens EVP, Global Manufacturing $2.96M May 28, 2024
William Burke EVP, Chief Financial Officer $2.62M Aug 23, 2021
Michelle L. Basil EVP and General Counsel $2.2M May 30, 2025
James DArecca EVP, Chief Financial Officer $1.96M May 30, 2025
Anila Lingamneni EVP, Chief Technology Officer $1.92M Jul 11, 2024
Mark W. Kroll Director $1.75M +$98.8K +5.99% Nov 10, 2025
Catherine M. Burzik Director $1.69M Aug 5, 2022
Stewart W. Strong President, Global Hospital $1.66M Jul 26, 2024
Charles J. Dockendorff Director $1.56M Jul 24, 2025
Robert E. Abernathy Director $1.56M Jul 24, 2025
Chad M. Nikel President, Global Plasma & BC $1.5M Aug 6, 2021
Laurie A. Miller SVP, Human Resources $1.44M Sep 17, 2025
Ellen M. Zane Director $1.21M Jul 24, 2025
Claire Pomeroy Director $1.05M Jul 24, 2025
Michael J. Coyle Director $962K Jul 24, 2025
Lloyd Emerson Johnson Director $808K Jul 24, 2025
Roy Galvin EVP, Chief Commercial Officer $641K Oct 31, 2025
Diane M. Bryant Director $445K Jul 24, 2025
Dan Goldstein VP, Corporate Controller $384K Jun 13, 2022
Jacqueline Scanlan SVP, Global Human Resources $364K Jun 7, 2021
Frank Chan EVP, Chief Operating Officer $352K May 16, 2025
Farris Maryanne Maunsell VP, Chief Accounting Officer $280K Jun 5, 2025

Recent Insider Transactions by Companies or Individuals for Haemonetics Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.